Tiziana Life Sciences Ltd
TLSA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $37,133 | $28,427 | $30,458 | $47,007 |
| - Cash | $3,724 | $1,183 | $18,122 | $42,186 |
| + Debt | $106 | $247 | $365 | $1,355 |
| Enterprise Value | $33,515 | $27,491 | $12,701 | $6,176 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$16,616 | -$17,136 | -$15,339 | -$26,340 |
| % Margin | – | – | – | – |
| Net Income | -$11,863 | -$17,691 | -$15,397 | -$23,417 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.22 | -0.34 | -0.3 | -0.48 |
| % Growth | 35.3% | -13.3% | 37.5% | – |
| Operating Cash Flow | -$1,219 | -$12,423 | -$15,990 | -$16,132 |
| Capital Expenditures | -$15 | $0 | $0 | -$16 |
| Free Cash Flow | -$1,235 | -$12,423 | -$15,990 | -$16,148 |